Description
Imigra 5 mg Capsule is a medication manufactured by Navana Pharmaceuticals Ltd., containing 5 mg of Flunarizine as the active ingredient. Flunarizine is a selective calcium channel antagonist and a difluorinated derivative of cinnarizine. It works by reducing excessive calcium influx into cells, thereby preventing cellular calcium overload. Additionally, Flunarizine exhibits antihistaminic and sedative properties.
Imigra 5 mg Capsule is indicated for the prophylaxis of classic (with aura) or common (without aura) migraine, symptomatic treatment of vestibular vertigo, peripheral vascular diseases (such as intermittent claudication, Raynaud's phenomenon, paresthesia, and cold extremities), motion sickness, and refractory epilepsy resistant to conventional antiepileptic therapy.
Change Language